Free Trial
→ What The Silver Boom Could Mean For You… (From Goldco Precious Metals) (Ad)tc pixel

CSL (OTCMKTS:CSLLY) Hits New 52-Week Low - Time to Sell?

Written by MarketBeat
September 23, 2025
CSL logo with Medical background

Key Points

  • CSL Limited (OTCMKTS:CSLLY) shares have reached a new 52-week low at $63.58, with a recent trading price of $65.90.
  • Zacks Research has downgraded CSL's stock rating from "hold" to "strong sell", while the overall consensus rating remains a "Moderate Buy."
  • The company maintains a quick ratio of 1.12, a current ratio of 2.46, and a debt-to-equity ratio of 0.50, indicating a relatively stable financial position.
  • Five stocks we like better than CSL.

CSL Limited Sponsored ADR (OTCMKTS:CSLLY - Get Free Report) shares reached a new 52-week low on Tuesday . The company traded as low as $63.58 and last traded at $65.90, with a volume of 6768 shares trading hands. The stock had previously closed at $65.57.

Wall Street Analyst Weigh In

Separately, Zacks Research cut shares of CSL from a "hold" rating to a "strong sell" rating in a research note on Monday, September 15th. One analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, CSL has a consensus rating of "Moderate Buy".

Read Our Latest Report on CSL

CSL Stock Performance

The company has a quick ratio of 1.12, a current ratio of 2.46 and a debt-to-equity ratio of 0.50. The company's 50 day simple moving average is $77.51 and its 200-day simple moving average is $78.19.

About CSL

(Get Free Report)

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CSL Right Now?

Before you consider CSL, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CSL wasn't on the list.

While CSL currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.